SCHEMBL2926667

SCHEMBL2926667

Cc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)C(Cl)C=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MMP9 P14780 9/20 0.57
▸ TDP1 Q9NUW8 1/20 0.56
▸ MMP2 P08253 9/20 0.55
▸ ADAMTS4 O75173 1/20 0.55
▸ CA2 P00918 1/20 0.55
▸ CA7 P43166 1/20 0.55
▸ CTSL P07711 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ ADAMTS5 Q9UNA0 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ GAA P10253 1/20 0.50
▸ MMP1 P03956 1/20 0.50
▸ MMP3 P08254 1/20 0.50
▸ MMP7 P09237 1/20 0.50
▸ MMP13 P45452 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4948256 1.00 MMP9 (0.57) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL8018411 0.88 MMP9 (0.61) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL617758 0.87 MMP9 (0.60) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL5481551 0.87 MMP9 (0.60) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL433896 0.85 MMP9 (0.67) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL561566 0.85 MMP9 (0.67) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL29961332 0.84 MMP9 (0.63) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL15213296 0.84 MMP9 (0.63) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL14519991 0.84 MMP9 (0.63) MMP9TDP1MMP2ADAMTS4CA2
SCHEMBL6331296 0.83 MMP9 (0.61) MMP9TDP1MMP2ADAMTS4CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708740-B1 PROTEASE INHIBITORS FOR THE TREATMENT OF DIGESTIVE PATHOLOGIES RYTEK (FR) 2010-09-29 — — EP claimed
JP-11228352-A — — None — — JP disclosed
WO-2024151802-A2 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ITCH PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-07-18 — — WO disclosed
WO-2018055235-A1 ISOXAZOLE-AMIDES FOR TREATING CARDIAC DISEASES UNIVERSITY OF HELSINKI (FI) 2018-03-29 — — WO disclosed
US-9841423-B2 Methods for diagnosing and treating Helicobacter pylori infection NATIONAL TSING HUA UNIVERSITY (TW) 2017-12-12 — — US disclosed
US-20170082621-A1 METHODS FOR DIAGNOSING AND TREATING HELICOBACTER PYLORI INFECTION NATIONAL TSING HUA UNIVERSITY (TW) 2017-03-23 — — US disclosed
WO-2016032319-A1 PROTEIN QUANTITATION WITH MASS SPECTROMETRY. ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) 2016-03-03 — — WO disclosed
US-8673312-B2 Method for one-step purification of recombinant Helicobacter pylori neutrophil-activating protein NATIONAL TSING HUA UNIVERSITY (TW) 2014-03-18 — — US disclosed
US-20130190482-A1 METHOD FOR ONE-STEP PURIFICATION OF RECOMBINANT HELICOBACTER PYLORI NEUTROPHIL-ACTIVATING PROTEIN NATIONAL TSING HUA UNIVERSITY (TW) 2013-07-25 — — US disclosed
EP-0739983-B1 Gene encoding lacto-n-biosidase TAKARA BIO INC (JP) 2009-12-30 — — EP disclosed
EP-1161452-B1 COVALENTLY BRIDGED INSULIN DIMERS SANOFI AVENTIS DEUTSCHLAND (DE) 2009-04-15 — — EP disclosed
EP-1588163-A2 KINASES AND GPCRS INVOLVED IN APOPTOSIS Eirx Therapeutics Ltd (IE) 2005-10-26 — — EP disclosed
US-20050019746-A1 Apoptosis-related kinase/GPCRs EIRX THERAPEUTICS LIMITED 2005-01-27 — — US disclosed
US-20040219616-A1 Apoptosis-related kinase/GPCRs EIRX THERAPEUTICS LIMITED 2004-11-04 — — US disclosed
WO-2004065959-A2 KINASES AND GPCRS INVOLVED IN APOPTOSIS EIRX THERAPEUTICS LIMITED (IE) 2004-08-05 — — WO disclosed
US-5985637-A DNA WHICH ENCODES AN ENZYME IMPORTANT IN CARBOHYDRATE ANALYSIS AND REARRANGEMENTS; FOR INDUSTRIAL-SCALE PRODUCTION OF ENZYME BY RECOMBINANT TECHNOLOGY TAKARA SHUZO CO., LTD. (JP) 1999-11-16 — — US disclosed
JP-H11228352-A HAIR TONIC AND HAIR TREATMENT KANEBO LTD 1999-08-24 — — JP disclosed
US-5908772-A A DNA SEQUENCE ENCODING A FUNCTIONALLY ACTIVE POLYPEPTIDE WHICH CATLYZES THE HYDROLYSIS OF LACTO-N-BIOSIDE BONDS; INDUSTRIAL SCALE PRODUCTION TAKARA SHUZO CO., LTD. (JP) 1999-06-01 — — US disclosed
EP-0769550-A2 Gene encoding endo-beta-n-acetyl glucosaminidase A TAKARA SHUZO CO. LTD. (JP) 1997-04-23 — — EP disclosed
EP-0739983-A2 Gene encoding lacto-n-biosidase TAKARA SHUZO CO. LTD. (JP) 1996-10-30 — — EP disclosed
Send feedback